View in EDS HTML Full Text PDF Full Text

Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma.

Saved in:
Bibliographic Details
Title: Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma.
Authors: Chinen, Yoshiaki1,2 (AUTHOR), Tanba, Kazuna1 (AUTHOR), Takagi, Ryo3 (AUTHOR), Uchiyama, Hitoji4 (AUTHOR), Uoshima, Nobuhiko5 (AUTHOR), Shimura, Kazuho6 (AUTHOR), Fuchida, Shin-ichi7 (AUTHOR), Kiyota, Miki8 (AUTHOR), Nakao, Mitsushige9 (AUTHOR), Tsukamoto, Taku2 (AUTHOR), Shimura, Yuji2 (AUTHOR), Kobayashi, Tsutomu2 (AUTHOR), Horiike, Shigeo2 (AUTHOR), Wada, Katsuya8 (AUTHOR), Shimazaki, Chihiro7 (AUTHOR), Kaneko, Hiroto6 (AUTHOR), Kobayashi, Yutaka5 (AUTHOR), Taniwaki, Masafumi6 (AUTHOR), Yokota, Isao3 (AUTHOR), Kuroda, Junya2 (AUTHOR)
Source: Leukemia & Lymphoma. Dec2020, Vol. 61 Issue 14, p3378-3386. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2020.1811862